Two Arrested With Huge Quantity Of Narcotic Drugs

Ludhiana: While many youths hooked to drugs were losing lives in the state, peddlers continue to supply banned drugs and injections to youngsters. Cracking a whip against the smugglers, the police today arrested two suspects and a huge number of banned drugs and injections were recovered from them, which they were supposed to sell to the youths directly or through agents.

Kuldeep Singh, a resident of Deloana village in Mansa and at present residing in Jassian, here, and Deepak Sharma, a resident of Ashok Nagar, Ludhiana, were nabbed by the PAU police when the duo were going on a scooter (bearing registration no PB10 JJ 3767) with a large number of banned drugs and injections.

The PAU police have registered a case under Sections 22, 61and 85 of the NDPS against the duo. While there has been no case registered against Deepak Sharma in the past, a case was registered against Kuldeep at Rajpura, Patiala, for smuggling drugs.

Dr GS Grewal, a physician, said the seized drugs were habit-forming medicines, which could not be sold without prescription and chemists give the same only to buyers after taking their identity proof. Tramadol was basically a derivative of opium which was given to patients having extreme pain. These come under the category of banned drugs, which could not be taken without doctor’s consultation.

The drugs that were seized from the suspects include 7,200 capsules of Acetaminophen Tramadol HCL and Dicyclomine HCL, 2,000 Tradamol prolonged release capsules, 900 Pentazocine Lactate and Penta 900 injections, 6,600 tablets of Alprazolam and Alpcore, 750 injections of Tramadol hydrochloride injection and Brutram.

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session